Precision BioSciences gets FDA clearance for ELIMINATE-B trial of PBGENE-HBV

Precision BioSciences has secured a major regulatory breakthrough as the U.S. Food and Drug Administration (FDA) granted clearance for its Investigational New Drug (IND) application ... Read More